NDST1 Gene: N-Deacetylase and N-Sulfotransferase 1
A key enzyme in heparan sulfate biosynthesis, implicated in developmental disorders and cancer.
Gene Information Card
| Symbol | NDST1 |
|---|---|
| Full Name | N-deacetylase and N-sulfotransferase 1 |
| Gene Type | protein coding |
| Chromosomal Location | 5q33.1 |
| NCBI Gene ID | 3340 ncbi.nlm.nih.gov/gene/3340 |
| Ensembl ID | ENSG00000070614 |
| UniProt ID | P21648 |
| OMIM ID | 600817 |
| HGNC ID | 7680 |
| Aliases | HSST, MST1, NST1 |
Description
The NDST1 gene encodes a type II transmembrane protein that is a bifunctional enzyme with N-deacetylase and N-sulfotransferase activities. It is involved in the biosynthesis of heparan sulfate, a glycosaminoglycan found on cell surfaces and in the extracellular matrix. NDST1 catalyzes the removal of acetyl groups from N-acetylglucosamine residues and the subsequent transfer of sulfate groups, a critical step in the modification of heparan sulfate chains. This modification is essential for the binding of heparan sulfate to various ligands, including growth factors, cytokines, and extracellular matrix proteins, thereby regulating multiple signaling pathways. NDST1 is widely expressed and plays a crucial role in embryonic development, particularly in the formation of the brain, skeleton, and other organs. Mutations in NDST1 have been associated with a rare autosomal recessive disorder characterized by intellectual disability, developmental delay, and skeletal abnormalities. Additionally, altered NDST1 expression has been observed in various cancers, suggesting a role in tumor progression and metastasis.
Disease Associations
| Disease category | Pathophysiological mechanism | Genomic evidence |
|---|---|---|
| Intellectual disability, autosomal recessive 55 | Loss-of-function mutations lead to reduced heparan sulfate sulfation, affecting signaling pathways critical for neurodevelopment. | ClinVar, OMIM |
| Skeletal abnormalities (e.g., short stature, brachydactyly) | Impaired heparan sulfate modification disrupts bone morphogenetic protein (BMP) and fibroblast growth factor (FGF) signaling during skeletal development. | OMIM, PubMed |
| Cancer (e.g., breast, colorectal, lung) | Altered NDST1 expression affects heparan sulfate structure, influencing tumor cell proliferation, invasion, and angiogenesis. | COSMIC, PubMed |
Expression Profile
Tissue Expression
| Tissue | nTPM | level |
|---|---|---|
| Brain | High | High |
| Lung | Medium | Medium |
| Liver | Medium | Medium |
| Kidney | Medium | Medium |
| Testis | High | High |
Cell Line Expression
| Cell Line | nTPM | Notes |
|---|---|---|
| HepG2 | Medium | Liver cancer cell line |
| A549 | Medium | Lung carcinoma cell line |
| MCF7 | Low | Breast cancer cell line |
| HEK293 | High | Embryonic kidney cells |
Data source:Human Protein Atlas(proteinatlas.org)
Mutations & Variants
Hotspot Mutations
| Variant | Type | Frequency | Functional Description |
|---|---|---|---|
| c.2602C>T (p.Arg868Ter) | Nonsense | Rare | Loss of function, likely leading to truncated protein |
| c.1990G>A (p.Gly664Arg) | Missense | Rare | Potential impact on enzyme activity |
| c.1A>G (p.Met1Val) | Start codon loss | Rare | Loss of translation initiation |
Mutation functional classification
Loss of Function (LOF)
Most reported pathogenic mutations are loss-of-function, leading to reduced or absent enzyme activity, resulting in impaired heparan sulfate modification.
Gain of Function (GOF)
No clear gain-of-function mutations have been reported; overexpression in some cancers may act as an oncogenic event.
Dominant Negative (DN)
Not well established; some missense mutations might exert a dominant-negative effect if the mutant protein interferes with the wild-type enzyme in oligomeric complexes.
View complete mutation data:
Gene Ontology (GO)
| • N-acetylglucosamine deacetylase activity | • N-sulfotransferase activity |
| • heparan sulfate proteoglycan biosynthetic process | • Golgi membrane |
| • integral component of membrane |
Pathways
• Heparan sulfate biosynthesis
• Glycosaminoglycan metabolism
• Signaling by Receptor Tyrosine Kinases (e.g.
• FGF
• VEGF)
Protein Summary
NDST1 is a 882-amino acid type II transmembrane protein localized to the Golgi apparatus. It consists of a short cytoplasmic tail, a transmembrane domain, and a large luminal catalytic domain. The protein forms homodimers and heterodimers with other NDST family members. It catalyzes the deacetylation and N-sulfation of N-acetylglucosamine residues in heparan sulfate, a critical step in the maturation of heparan sulfate chains. This modification is essential for the binding of heparan sulfate to a variety of ligands, including growth factors and morphogens, thereby regulating developmental processes and adult tissue homeostasis. Mutations in NDST1 lead to a rare autosomal recessive disorder with intellectual disability and skeletal defects. In cancer, altered NDST1 expression can modify the tumor microenvironment and promote metastasis.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| NDST1 Knockout HEK293 Cell Line | EDJ-KQ4951 | Human | 3340 | Details Get a Quote |
| NDST1 Knockout HeLa Cell Line | EDJ-KQ26602 | Human | 3340 | Details Get a Quote |
| NDST1 Knockout A-549 Cell Line | EDJ-KQ27817 | Human | 3340 | Details Get a Quote |
| NDST1 Knockout HCT 116 Cell Line | EDJ-KQ27818 | Human | 3340 | Details Get a Quote |
Displaying Records 1 To 4 Of 4 Records